Speakers
Johanna Bendell
Head of Oncology
Pfizer
Kate Bingham
Managing Partner
SV Health Investors
Kevin Eggan
Chief Scientific Officer
Biomarin
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
Tim Funnell
Partner
Monograph Capital
Shaun Grady
Chair, U.K.
AstraZeneca
Anika Gupta, Ph.D.
Principal
GV
Stephen Hansen
Director of Biopharma Intelligence
BioCentury Inc.
Susan Hill, Ph.D.
CEO
Mestag Therapeutics
Steve Jackson
Professor of Biology, Cambridge and Group Leader
Cancer Research UK
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
John Lepore, M.D.
CEO
ProFound Therapeutics
Husseini Manji, M.D.
Professor, Oxford University & Visiting Professor, Duke University and Co-chair,
UK Govt Mental Health Mission
Jane Osbourn, Ph.D.
CEO
Alchemab Therapeutics Ltd.
Koustubh Ranade, Ph.D.
SVP and Head of Translational Medicine
Immunocore
Steve Rees
SVP Discovery Sciences
AstraZeneca
James Sabry, M.D., Ph.D.
EVP and CBO
BioMarin
Chris Sheldon, Ph.D.
SVP & Global Head of Business Development R&D
GlaxoSmithKline
Paul Peter Tak, M.D., Ph.D.
President and CEO
Candel Therapeutics
Victoria Taylor
Associate
Medicxi
Sarah Teichmann
Professor and Chair
Cambridge Stem Cell Institute
Richard Tillyer, Ph.D.
Global Head, Discovery, Product Development and Supply
Johnson & Johnson Innovative Medicine
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
Patrick Vallance, KCB
Minister of State for Science, Research and Innovation
Department for Science, Innovation and Technology
Jérôme Van Biervliet, Ph.D.
Managing Director
VIB
Annelise Vuidepot, PhD
SVP, CTO, Research and UK Site Lead
Immunocore Holdings plc